Canada suspended AstraZeneca vaccination for people under 55

Canada suspended AstraZeneca vaccination for people under 55.  As the COVID-19 vaccine produced by AstraZeneca has recently been accused of the risk of causing thrombosis, Canadian officials announced on March 29 that they will suspend the vaccination of people under 55 years of age.

The Public Health Agency of Canada stated that this decision was based on the rare “vaccine-induced thrombotic immune thrombocytopenia” (VIPIT) example reported in Europe, and the associated high mortality rate and associated serious consequences. The Public Health Agency also stated that there have been no reports of such adverse events in Canada so far, and the vaccine has not yet been widely used in the country.

Health Canada has released AstraZeneca’s COVID-19 vaccine label update and related guidelines on March 24 to supplement its risk information. The Canadian Ministry of Health will also require AstraZeneca manufacturers to provide risk assessment information for different age and gender groups within Canada.

The National Advisory Committee on Immunization of Canada recommended earlier this month not to vaccinate AstraZeneca for people 65 years of age and older. The committee has now recommended an immediate suspension of the vaccine in people under 55 years of age. The Department of Public Health decided to take “decisive action” to restrict use from a unified standpoint.

The health department also reminded that people who have been vaccinated for less than 20 days, or who will be vaccinated in the future and have unhealthy symptoms 4 days after vaccination, should seek medical attention immediately. The health department will decide how to inject the second dose of vaccine based on the latest research results.

At the end of February, Canadian authorities approved the COVID-19 vaccine developed by AstraZeneca and Oxford University and the AstraZeneca vaccine produced by the Serological Institute of India. There are three other COVID-19 vaccines that have been approved in Canada: the vaccine jointly developed by Pfizer and the German biotech company, the Moderna vaccine in the United States, and the Johnson & Johnson vaccine that only requires a single injection.

At present, the COVID-19 epidemic in Canada is showing a more obvious rebound. In Ontario, which has the highest cumulative number of cases, the number of new cases in a single day has risen to around 2,000. The province’s COVID-19 scientific advisory group believes that mutated COVID-19 virus infections account for about 60% or more of the new cases, and the epidemic is out of control.

The province of British Columbia on the west coast announced a three-week escalation of restrictions starting March 30, suspending catering services in the catering industry, indoor multi-person fitness, indoor religious worship, etc., and urged people to work at home as much as possible.

As of the evening of March 29, Canada had reported a total of about 971.7 thousand cases, 903,600 recovered cases, 22,900 deaths, and 45,208 active cases.

(source:internet, reference only)

Disclaimer of medicaltrend.org